QUALITY OF LIFE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MYELOFIBROSIS

被引:0
|
作者
Machate, N. [1 ]
Alchalby, H. [1 ]
Zabelina, T. [1 ]
Wulf, G. [2 ]
Sehner, S. [1 ]
Wolff, D. [3 ]
Kobbe, G. [4 ]
Bornhaeuser, M. [5 ]
Baurmann, H. [6 ]
Bethge, W. [7 ]
Zander, A. [1 ]
Kroeger, N. [1 ]
机构
[1] Univ Hamburg Hosp, Hamburg, Germany
[2] Univ Hosp, Gottingen, Germany
[3] Univ Hosp, Regensburg, Germany
[4] Univ Hosp, Dusseldorf, Germany
[5] Univ Hosp, Dresden, Germany
[6] DKD Clin, Wiesbaden, Germany
[7] Univ Hosp, Tubingen, Germany
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
PH-O058
引用
收藏
页码:S31 / S32
页数:2
相关论文
共 50 条
  • [1] Quality Of Life After Allogeneic Stem Cell Transplantation In Patients With Myelofibrosis (CMWP of EBMT)
    Machate, Nora
    Alchalby, Haefaa
    Sehner, Susanne
    Zabelina, Tatjana
    Wolff, Daniel
    Kobbe, Guido
    Bornhaeuser, Martin
    Baurmann, Herrad
    Bethge, Wolfgang A.
    Wulf, Gerald
    Zander, Axel R.
    Kroeger, Nicolaus
    BLOOD, 2013, 122 (21)
  • [2] Quality of life in patients after allogeneic haematopoietic stem cell transplantation
    Stancheva, N.
    Semenova, E.
    Zubarovskay, N.
    Paina, O.
    Vasilieva, Y.
    Alyansky, A.
    Bagge, D.
    Afanasyev, B.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S88 - S88
  • [3] Outcome of allogeneic stem cell transplantation in patients with myelofibrosis
    M Ditschkowski
    D W Beelen
    R Trenschel
    M Koldehoff
    A H Elmaagacli
    Bone Marrow Transplantation, 2004, 34 : 807 - 813
  • [4] Outcome of allogeneic stem cell transplantation in patients with myelofibrosis
    Ditschkowski, M
    Beelen, DW
    Trenschel, R
    Koldehoff, M
    Elmaagacli, AH
    BONE MARROW TRANSPLANTATION, 2004, 34 (09) : 807 - 813
  • [5] Relapse-therapy for myelofibrosis patients after allogeneic stem cell transplantation
    Klyuchnikov, E.
    Alchalby, H.
    Badbaran, A.
    Wolschke, C.
    Ayuk, F.
    Bacher, U.
    Zander, A.
    Kroeger, N.
    ONKOLOGIE, 2010, 33 : 228 - 228
  • [6] Factors influencing the engraftment in patients with myelofibrosis after allogeneic stem cell transplantation
    Hart, C.
    Barop, J.
    Mueller, G.
    Schelker, R.
    Herr, W.
    Holler, E.
    Grassinger, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 230 - 230
  • [7] Splenectomy after allogeneic haematopoietic stem cell transplantation in patients with primary myelofibrosis
    Robin, Marie
    Esperou, Helene
    de Latour, Regis Peffault
    Petropoulou, Anna D.
    Xhaard, Alienor
    Ribaud, Patricia
    Socie, Gerard
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 150 (06) : 721 - 724
  • [8] Relapse-therapy for myelofibrosis patients after allogeneic stem cell transplantation
    Klyuchnikov, E.
    Alchalby, H.
    Badbaran, A.
    Wolschke, C.
    Ayuk, F.
    Bacher, U.
    Zander, A.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S243 - S243
  • [9] Allogeneic Stem Cell Transplantation in Myelofibrosis
    Jain, Tania
    Mesa, Ruben A.
    Palmer, Jeanne M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (09) : 1429 - 1436
  • [10] Quality of Life Following Allogeneic Stem Cell Transplant for Myelofibrosis
    Palmer, Jeanne
    Fauble, Veena
    Geyer, Holly
    Kosiorek, Heidi
    Dueck, Amylou
    Mesa, Ruben A.
    Jain, Tania
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S198 - S198